Persistent Atrial Fibrillation
208
32
54
73
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
38 trials with published results (18%)
Research Maturity
73 completed trials (35% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
5.8%
12 terminated out of 208 trials
85.9%
-0.7% vs benchmark
5%
11 trials in Phase 3/4
52%
38 of 73 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 73 completed trials
Clinical Trials (208)
Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Feasibility Study of the FARAFLEX Mapping and PFA System
Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
PLAI-AF Trial: Hybrid Endo-epicardial Partial Left Atrial Isolation vs. Endocardial Ablation in Patients With Persistent Atrial Fibrillation
A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System
Lattice vs Pentaspline Comparative Evaluation in Persistent AF
Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
iCLAS™ for Persistent Atrial Fibrillation
VOLT-AF IDE Clinical Study
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
The PIFPAF-PFA Study